title: Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy.
abstract: The development of lentigines in areas previously involved by psoriasis has been reported in the literature, classically related to phototherapy but also to topical products. More recently, some authors have described several cases of lentigines appearing in resolving psoriatic plaques during or after treatment with anti-tumour necrosis factor (TNF) drugs used to treat severe plaque psoriasis, including adalimumab, etanercept, and infliximab. We report the case of a patient that developed multiple lentigines after clearance of the plaques of psoriasis receiving treatment with ustekinumab for his psoriasis.
authors.affiliation: Hospital San Agustín, Avilés (Asturias), Spain.
authors.forename: E
authors.initials: E
authors.lastname: Gutiérrez-González
authors.forename: A
authors.initials: A
authors.lastname: Batalla
authors.forename: D
authors.initials: D
authors.lastname: de la Mano
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D018664:Interleukin-12 / Q000037:antagonists & inhibitors; D053759:Interleukin-23 / Q000037:antagonists & inhibitors; D007911:Lentigo / Q000209:etiology* / Q000473:pathology; D008297:Male; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy*; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D053759:Interleukin-23; D018664:Interleukin-12; D000069549:Ustekinumab